IGF1 and prostate carcinoma: Catechins are reported to inhibit prostate cancer growth, induce intrinsic and extrinsic apoptotic pathways, decrease inflammation by inhibiting COX-2 levels and IGF-1-related signalling, and exert antioxidant properties [3, 39].